TNF Pharma and Renova Health Find Targets for GLP-1 Inflammation Treatment
May 8, 2025
Use of AI and machine learning accelerates identification of patient groups whose care can be improved TNF Pharmaceuticals, Inc, a clinical stage biopharmaceutical company committed